These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17320237)

  • 1. Triple oral therapy for type 2 diabetes.
    Bell DS
    Diabetes Res Clin Pract; 2007 Dec; 78(3):313-5. PubMed ID: 17320237
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes.
    Charbonnel B
    Int J Clin Pract Suppl; 2007 Jun; (153):1-2. PubMed ID: 17594387
    [No Abstract]   [Full Text] [Related]  

  • 3. Glitazones in type 2 diabetes: an update.
    Drug Ther Bull; 2008 Apr; 46(4):25-9. PubMed ID: 18403615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing diabetes. Recommendations and caveats.
    Harris S
    Can Fam Physician; 2005 May; 51(5):637-9, 644-6. PubMed ID: 15934259
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin sensitizer affects lipids.
    Health News; 2005 Jan; 11(1):2. PubMed ID: 15726701
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment on: Boden et al. (2007) Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention: Diabetes 56:248-255.
    Karalliedde J; Viberti GC
    Diabetes; 2007 May; 56(5):e3; author reply e4. PubMed ID: 17470560
    [No Abstract]   [Full Text] [Related]  

  • 7. Actos and Avandia in type 2 diabetes. Where do they fit?
    Clark W
    Diabetes Self Manag; 2007; 24(4):8, 11-3. PubMed ID: 17663078
    [No Abstract]   [Full Text] [Related]  

  • 8. [Consulting Prof. Dr. Stephan Matthaei. Quakenbrück diabetes center. Prescription relevant conclusions].
    Matthaei S
    MMW Fortschr Med; 2007 Apr; 149(15):53. PubMed ID: 17668779
    [No Abstract]   [Full Text] [Related]  

  • 9. [Insulin sensitizers is now approved as monotherapy as well. Lowering blood pressure with added effects].
    MMW Fortschr Med; 2003 Oct; 145(41):47. PubMed ID: 14655486
    [No Abstract]   [Full Text] [Related]  

  • 10. [Timely intervention with insulin sensitizer. Controlling cardiovascular risks].
    MMW Fortschr Med; 2003 Jun; 145(23):56-7. PubMed ID: 12854228
    [No Abstract]   [Full Text] [Related]  

  • 11. Drugs for type 2 diabetes.
    Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetes.
    Schimke K; Davis TM
    Curr Opin Investig Drugs; 2007 Apr; 8(4):338-44. PubMed ID: 17458185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choosing first-line therapy for management of type 2 diabetes.
    Graber MA; Darby-Stewart A; Dachs R
    Am Fam Physician; 2008 Jan; 77(1):16-7. PubMed ID: 18236820
    [No Abstract]   [Full Text] [Related]  

  • 14. PROactive Study: (r)evolution in the therapy of diabetes?
    Ceriello A
    Diabet Med; 2005 Nov; 22(11):1463-4. PubMed ID: 16241907
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
    MMW Fortschr Med; 2007 Aug; 149(31-32):52-3. PubMed ID: 17849787
    [No Abstract]   [Full Text] [Related]  

  • 16. Pioglitazone + glimepiride: a combination product to avoid.
    Prescrire Int; 2007 Aug; 16(90):145. PubMed ID: 17724836
    [No Abstract]   [Full Text] [Related]  

  • 17. Rosiglitazone + glimepiride: new drug. Another combination product to avoid.
    Prescrire Int; 2007 Aug; 16(90):144. PubMed ID: 17726795
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
    Nathan DM; Buse JB; Davidson MB; Ferrannini E; Holman RR; Sherwin R; Zinman B
    Diabetes Care; 2008 Jan; 31(1):173-5. PubMed ID: 18165348
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is there a need of glitazones in the treatment of diabetes?].
    Halse J
    Tidsskr Nor Laegeforen; 2007 Aug; 127(16):2124; author reply 2124. PubMed ID: 17717584
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of patients with type 2 diabetes mellitus with pioglitazone. A survey of a Cochrane review].
    Madsbad S
    Ugeskr Laeger; 2007 Nov; 169(47):4054-7. PubMed ID: 18078659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.